Founded
23 Jun 1997

Address

Bay City Capital LLC
750 Battery Street
Suite 400
San Francisco, CA 94111
United States

Open Map


VCID: 2637
    Profile

    Corporate information


    Registration country
    Investment activity status
    Active investor

    Selected investments

    Country Date Notes
    Nevro Corp
    Medical device company marketing novel neuromodulation therapies for the treatment of chronic, intractable pain.
    United States 1 Aug 2008
    1 Jul 2011
    N/A
    Calypso Medical Technologies Inc
    A medical device company developing innovative tools and therapies for the oncology marketa advancing cancer radiation treatment.
    United States 2 Nov 2009
    7 Jan 2005
    Series E
    Round participant. Active
    Metabolex Inc
    Focuses on the discovery and development of novel therapeutics for the treatment of diabetes.
    United States 1 Apr 2007
    1 Nov 2009
    N/A
    Presidio Pharmaceuticals Inc
    Drug discovery and development, focused on anti-viral indications
    United States 1 Aug 2007
    1 Jul 2009
    N/A
    Nextwave Pharmaceuticals Inc
    Specialty pharmaceutical company, focused on pediatric neurology.
    United States N/A
    Active
    EnteroMedics Inc
    Develops therapeutic devices for the treatment of obesity. Its VSM technology uses electrical signals, delivered by an implantable electrode array, to
    United States N/A
    Madrigal Pharmaceuticals Inc
    Drug development company focused on building a pipeline of small-molecule drugs for the treatment of cardiovascular and metabolic diseases.
    United States N/A
    ReSet Therapeutics Inc
    United States N/A
    Chemdex
    Internet clearinghouse to facilitate the distribution of specialty chemicals, biochemicals, and reagents.
    United States N/A
    Medarex Inc
    Creates and develops therapeutic products for cancer, autoimmune disease and other life-threatening and debilitating diseases.
    United States N/A
    Sembiosys Genetics Inc
    Developer of high value proteins and oil body based products for personal care, nutrition and pharmaceutical industries.
    Canada N/A
    Active
    Aciex Therapeutics Inc
    Specialty pharmaceutical company focused on the development of therapeutics to treat front of the eye diseases.
    United States N/A
    Epizyme Inc
    Focusing on the discovery and development of innovative drugs targeting epigenetic enzymes, in particular histone methyltransferases (HMTs).
    United States N/A
    MAP Pharmaceuticals Inc
    Proprietary inhalation technologies to enhance the therapeutic benefits and commercial attractiveness of proven drugs. 
    United States N/A
    Sunesis Pharmaceuticals Inc
    Sunesis is a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and he
    United States N/A
    Eos Biotechnology Inc
    Next generation genomics company that uses the complete human genome to identify new drug targets and develop antibodies against those targets to trea
    United States N/A

    DISCLAIMER: This chart is based on a limited amount of data and may change once additional information has been added. We are working hard to ensure the completeness of the data. If you want to assist us in our work, please contact us using this form.